ArticleJournal for immunotherapy of cancer2025

Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors.

Jason J Luke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.